Effects of the cannabinoid receptor agonist CP-55,940 on incentive salience attribution
Ali Gheidi, Lora M. Cope, Christopher J. Fitzpatrick, Benjamin Froehlich, Rachel Atkinson, Coltrane K. Groves, Clair N. Barcelo, Jonathan D. Morrow
This study investigates how the cannabinoid agonist CP-55,940 affects sign-tracking and goal-tracking behaviors in rats, finding that it decreases sign-tracking and increases goal-tracking in a dose-dependent manner.
Psychopharmacology · Jun 3, 2020Peer-reviewedNeuroscience